PL1819230T3 - Makrocząstki pochodzące z czerwonych krwinek jako czynniki hemostatyczne do kontrolowania krwotoku i do leczenia zaburzeń krwawienia - Google Patents
Makrocząstki pochodzące z czerwonych krwinek jako czynniki hemostatyczne do kontrolowania krwotoku i do leczenia zaburzeń krwawieniaInfo
- Publication number
- PL1819230T3 PL1819230T3 PL05849361T PL05849361T PL1819230T3 PL 1819230 T3 PL1819230 T3 PL 1819230T3 PL 05849361 T PL05849361 T PL 05849361T PL 05849361 T PL05849361 T PL 05849361T PL 1819230 T3 PL1819230 T3 PL 1819230T3
- Authority
- PL
- Poland
- Prior art keywords
- microparticles
- derived
- hemorrhage
- treatment
- control
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63341704P | 2004-12-07 | 2004-12-07 | |
EP05849361A EP1819230B1 (en) | 2004-12-07 | 2005-12-07 | Red cell-derived microparticles as hemostatic agents for the control of hemorrhage and for treatment of bleeding disorders |
PCT/US2005/044064 WO2006062945A2 (en) | 2004-12-07 | 2005-12-07 | Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1819230T3 true PL1819230T3 (pl) | 2013-02-28 |
Family
ID=36578476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05849361T PL1819230T3 (pl) | 2004-12-07 | 2005-12-07 | Makrocząstki pochodzące z czerwonych krwinek jako czynniki hemostatyczne do kontrolowania krwotoku i do leczenia zaburzeń krwawienia |
Country Status (9)
Country | Link |
---|---|
US (1) | US8105632B2 (pl) |
EP (1) | EP1819230B1 (pl) |
JP (1) | JP5204490B2 (pl) |
AT (1) | ATE555799T1 (pl) |
DK (1) | DK1819230T3 (pl) |
ES (1) | ES2390317T3 (pl) |
PL (1) | PL1819230T3 (pl) |
PT (1) | PT1819230E (pl) |
WO (1) | WO2006062945A2 (pl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155764B1 (en) * | 2004-12-07 | 2015-10-13 | University Of Miami | Expanded utility of red-cell derived microparticles (RMP) for treatment of bleeding |
CN101304748A (zh) | 2005-08-22 | 2008-11-12 | 加利福尼亚大学董事会 | Tlr激动剂 |
BRPI0807196A2 (pt) * | 2007-02-07 | 2014-06-03 | Univ California | Método para prevenir ou inibir uma infecção bacteriana, vacina, composto, e, método para prevenir, tratar ou inibir a asma |
FR2917172B1 (fr) * | 2007-06-07 | 2014-01-03 | Inst Nat Sante Rech Med | Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation |
US20090062233A1 (en) | 2007-08-09 | 2009-03-05 | Xin Ji | Modified starch material of biocompatible hemostasis |
US20120116817A1 (en) * | 2009-07-01 | 2012-05-10 | Chantal Boulanger | Methods for Predicting Cardiovascular Mortality Risk |
WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
NO2668262T3 (pl) * | 2011-01-28 | 2018-04-28 | ||
JP2012168012A (ja) * | 2011-02-14 | 2012-09-06 | Nippon Koden Corp | 血管内皮障害を検査するための新規な検査方法および検査用キット |
WO2012135032A2 (en) * | 2011-03-25 | 2012-10-04 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory particles |
US10004764B2 (en) | 2013-11-07 | 2018-06-26 | University of Pittsburgh—of the Commonwealth System of Higher Education | Red blood cell membrane-derived microparticles and their use for the treatment of lung disease |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
US10538738B2 (en) * | 2014-05-19 | 2020-01-21 | Eleftherios Papoutsakis | Megakaryocytic particles and microparticles for cell therapy and fate modification of stem and progenitor cells |
WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
WO2016141325A1 (en) | 2015-03-04 | 2016-09-09 | University Of Rochester | Systemic and topical application of platelet microparticles to treat bleeding in trauma patients |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
WO2017062422A1 (en) * | 2015-10-07 | 2017-04-13 | The Research Foundation For The State University Of New York | METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXβ REDUCTASE |
US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | CELL EXPANSION |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
JP6896516B2 (ja) * | 2016-07-25 | 2021-06-30 | シスメックス株式会社 | 血液分析装置および血液分析方法 |
CN110799199B (zh) | 2016-11-30 | 2024-01-30 | 迈阿密大学 | Rmp组合物及使用方法 |
EP3656842A1 (en) | 2017-03-31 | 2020-05-27 | Terumo BCT, Inc. | Cell expansion |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP2024511064A (ja) | 2021-03-23 | 2024-03-12 | テルモ ビーシーティー、インコーポレーテッド | 細胞捕獲及び増殖 |
CN117752686A (zh) * | 2022-11-18 | 2024-03-26 | 中山大学 | 囊泡在制备体外促凝血或体外止血药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1131106B1 (en) * | 1998-11-12 | 2009-06-24 | Novolytics Inc. | Compositions and methods for producing vascular occlusion |
-
2005
- 2005-12-07 AT AT05849361T patent/ATE555799T1/de active
- 2005-12-07 PT PT05849361T patent/PT1819230E/pt unknown
- 2005-12-07 PL PL05849361T patent/PL1819230T3/pl unknown
- 2005-12-07 JP JP2007544614A patent/JP5204490B2/ja active Active
- 2005-12-07 US US11/792,399 patent/US8105632B2/en active Active
- 2005-12-07 EP EP05849361A patent/EP1819230B1/en active Active
- 2005-12-07 WO PCT/US2005/044064 patent/WO2006062945A2/en active Application Filing
- 2005-12-07 DK DK05849361.0T patent/DK1819230T3/da active
- 2005-12-07 ES ES05849361T patent/ES2390317T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
WO2006062945A2 (en) | 2006-06-15 |
PT1819230E (pt) | 2012-08-07 |
EP1819230A4 (en) | 2009-08-12 |
JP2008522974A (ja) | 2008-07-03 |
US8105632B2 (en) | 2012-01-31 |
JP5204490B2 (ja) | 2013-06-05 |
ATE555799T1 (de) | 2012-05-15 |
WO2006062945A3 (en) | 2006-12-07 |
US20080069807A1 (en) | 2008-03-20 |
EP1819230A2 (en) | 2007-08-22 |
EP1819230B1 (en) | 2012-05-02 |
ES2390317T3 (es) | 2012-11-08 |
DK1819230T3 (da) | 2012-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1819230T3 (pl) | Makrocząstki pochodzące z czerwonych krwinek jako czynniki hemostatyczne do kontrolowania krwotoku i do leczenia zaburzeń krwawienia | |
EP4026835A3 (en) | Pd-1/pd-l1 inhibitors | |
PH12020551062A1 (en) | 1,2,4-oxadiazole compounds as inhibitors of cd47 signalling pathways | |
MX2021001186A (es) | Purinonas como inhibidores de proteasa especifica de ubiquitina 1. | |
AU2018236800B2 (en) | DNA-PK inhibitors | |
EA201891268A1 (ru) | Соединения, которые можно применять в качестве ингибиторов киназы | |
MX2019002564A (es) | Composiciones de agente de unión de albúmina-paclitaxel y métodos de uso y elaboración de las mismas. | |
EP4276114A3 (en) | Cd20 binding single domain antibodies | |
PH12015501656B1 (en) | Anti-il-33 antibodies and use thereof | |
PH12015502388A1 (en) | Compositions and methods for altering second messenger signaling | |
NZ701121A (en) | Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof | |
PH12020500343A1 (en) | Pyruvate kinase activators for use in treating blood disorders | |
ATE553093T1 (de) | Indazolderivate zur hemmung von trpv1 und verwendungen davon | |
MX2020002399A (es) | Inhibidores del enlace proteína-proteína de wdr5. | |
EA201691235A1 (ru) | Модифицированные серпины для лечения нарушений свертываемости крови | |
GEP201706741B (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | |
TW200734306A (en) | Novel compounds, their preparation and use | |
MX2012013078A (es) | Composiciones antimicrobianas liquidas de baja formacion de espuma, modificadas reologicamente, y sus metodos de uso. | |
MX2020002435A (es) | Agentes que modulan las funciones de beta-catenina y sus métodos. | |
EA201501123A8 (ru) | Новые (циано-диметил-метил)-изоксазолы и -[1,3,4]тиадиазолы | |
WO2017007886A3 (en) | Compositions for inhibiting dux4 gene expression and uses thereof | |
MX2022014220A (es) | Inhibidores de calmodulin, inhibidores de chk2 e inhibidores de rsk para el tratamiento de trastornos ribosomales y ribosomatopias. | |
IL184292A0 (en) | Treatment of drug-resistant proliferative disorders | |
MX2022007207A (es) | Composiciones y metodos para tratar y prevenir la influenza. | |
MX2020006533A (es) | Inhibidores del receptor activado por proteasa-2. |